| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |